Venture Connect returned to an in-person format for the first time since 2019 on April 6-7.
CISCO Systems Campus
Research Triangle Park
7025-5 Kit Creek Rd, Morrisville, NC 27560
Thanks to all that attended, supported, and participated in Venture Connect 2022. Not only did we have an amazing turn-out with over 900 tickets sold, valuable content was shared and new connections were made throughout the day.
A very special thank you to our event sponsors, celebration vendors, and Cisco Systems.
We’d also like to thank the volunteers who took time out of their busy schedules to assist us. Venture Connect 2022 couldn’t have been a success without you!
Who attends Venture Connect Summit? CED strives to create an environment where attendees can connect to the resources they seek. You should attend if you are a:
Regional start-up or growth-stage company that is scaling fast.
Local or out-of-state investors looking to connect with scaling ventures.
Corporate and strategic partner who is highly invested in the NC ecosystem.
Community resources aligned with accelerating the growth of companies.
Explorers looking to connect with others in the ecosystem.
Featured companies at Venture Connect presented on stage in front of investors, corporate partners, ecosystem resources, and potential talent. We saw high growth, scalable ventures in Life Sciences, Technology, Food Innovation, CPG, and more.
Aer Therapeutics is a privately held, clinical-stage biopharmaceutical company developing novel, best in class inhaled mucolytics for lung diseases. Aer Therapeutics is a start-up biopharmaceutical company jointly located in Raleigh NC. The company is focused on treating respiratory diseases with significant unmet medical needs, such as asthma, COPD and cystic fibrosis with an initial focus on developing the first inhaled anti-mucolytic treatment for asthma and COPD. Aer Therapeutics combines a deep understanding of patient subtypes, of mechanisms of mucus pathology, and of inhaled drug delivery to address the unmet needs in these diseases. Aer Therapeutic’s technology was developed at UCSF in Dr. John Fahy’s lab working in collaboration with Irish researchers Stefan Oscarson and Anne Marie Healy from University College Dublin and Trinity College Dublin respectfully with robust funding from the NIH. The technology relies on small molecules, designed for inhaled delivery, to lyse thick, highly elastic mucus and improve mucus clearance, reduce inflammation, and subsequently improve lung function and lung health.
AnelleO, Inc.
AnelleO is harnessing the advancements in the speed and scale of 3D printing technology for novel solutions in Women’s Health. Intravaginal Rings (IVR) offer a unique platform for sustained delivery of therapeutics – a non-invasive, self- administered and retrievable platform that can deliver drugs over a period of weeks or months. To-date, IVR technology has been limited to a few successes due to inherent limitations of current manufacturing by injection molding or extrusion. The design flexibility, rapid prototyping, and cost-effective manufacturing of digital light synthesis (DLS) 3D printing allows AnelleO to develop and manufacture IVRs specifically matched to the unique characteristics of the molecule and indication. AnelleO’s lead product is AnelleO PRO – a self- administered, non-invasive multi-week alternative to daily progesterone supplementation alongside Assisted Reproductive Technologies (ART) for women undergoing fertility treatment.
Blue Recruit, Inc
BlueRecruit is a software platform that connects America’s blue-collar skilled workers with the companies desperate for their talent.
CelerPurus
CelerPurus is bringing the Purus One Ultraviolet chamber, a point-of-care solution for decontaminating masks and other personal items, to market. Details on the company and the product itself can be found at: https://www.celerpurus.com/product. CelerPurus was established in 2020 and has been refined over the course of 2020 and 2021 to meet the discovered needs of end users and customers. The invention applies proven UV light decontamination technology combined with a Patent Pending application of the technology in a unique and compelling manner. No product currently commercially available can decontaminate masks and a range of personal items faster and with greater efficacy than the CelerPurus Purus One device.
Chekhub, Inc.
Chekhub is a B2B SaaS software company founded in March of 2020 by serial entrepreneur Jon Trout. The company’s vision is to create a software solution to solve the operational challenges he faced in his last startup, Bitbox USA. Chekhub’s focus is to provide an operational management software platform to help provide clarity, precision, and efficiency to your entire organization. Chekhub’s focus is to help operational leaders improve their organization’s performance similar to how Salesforce helped sales leaders.
sponsors
Venture Connect attracts all types of resources from the entrepreneurial ecosystem that enable startups to accelerate their growth. Sponsors include investors, professional service partners, other startups, community resources, and more. Learn more about our sponsors.
Ecosystem Sponsor
Deloitte LLP
Investor Dinner
Hutchison PLLC
Investor Dinner
Pacific Western Bank
Investor Dinner
T3 Advisors
Industry Insight Sponsor
JPMorgan Chase & Co.
Ecosystem Sponsor
Deloitte LLP
Investor Dinner
Hutchison PLLC
Investor Dinner
Pacific Western Bank
Investor Dinner
T3 Advisors
Industry Insight Sponsor
JPMorgan Chase & Co.
more info
Looking for more information? Here are some helpful links that can get you where you need to be… Agenda, Celebration.